Early trial tests new drug for Tough-to-Treat blood cancer
NCT ID NCT03287908
Summary
This early-stage study tested a new drug called AMG 701, both alone and combined with other medications, for adults with multiple myeloma that had returned or stopped responding to many prior treatments. The main goals were to find a safe and effective dose and to see how the body processes the drug. The trial was terminated early and did not progress to later phases.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University Medical Center
New York, New York, 10032, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Gunma University Hospital
Maebashi, Gunma, 371-8511, Japan
-
Hackensack University Medical Center
Hackensack, New Jersey, 07601, United States
-
Icahn School of Medicine at Mount Sinai
Hackensack, New Jersey, 07601, United States
-
Kanazawa University Hospital
Kanazawa, Ishikawa-ken, 920-8641, Japan
-
Kobe City Medical Center General Hospital
Kobe, Hyōgo, 650-0047, Japan
-
Levine Cancer Institute
Charlotte, North Carolina, 28204, United States
-
Maastricht Universitair Medisch Centrum
Maastricht, 6229 HX, Netherlands
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Mayo Clinic - Arizona
Scottsdale, Arizona, 85259, United States
-
Mayo Clinic Florida
Jacksonville, Florida, 32224, United States
-
McGill University Health Centre Glen Site
Montreal, Quebec, H4A 3J1, Canada
-
Nagoya City University Hospital
Nagoya, Aichi-ken, 467-8602, Japan
-
National Hospital Organization Okayama Medical Center
Okayama, Okayama-ken, 701-1192, Japan
-
New York Presbyterian Hospital, Weill Cornell Medical College
New York, New York, 10065, United States
-
Peter MacCallum Cancer Centre
Melbourne, Victoria, 3000, Australia
-
Princess Alexandra Hospital
Woolloongabba, Queensland, 4102, Australia
-
The Alfred Hospital
Melbourne, Victoria, 3004, Australia
-
The Cancer Institute Hospital of Japanese Foundation for Cancer Research
Koto-ku, Tokyo, 135-8550, Japan
-
The Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
Universitaetsklinikum Wuerzburg
Würzburg, 97080, Germany
-
Universitair Medisch Centrum Groningen
Groningen, 9713 GZ, Netherlands
-
Universitair Medisch Centrum Utrecht
Utrecht, 3584 CX, Netherlands
-
University Health Network-Princess Margaret Cancer Centre
Toronto, Ontario, M5G 1X6, Canada
-
University of Arkansas for Medical Sciences Myeloma Institute Slot 816
Little Rock, Arkansas, 72205, United States
-
University of Chicago Medical Center - Multiple Myeloma Research Consortium
Chicago, Illinois, 60637, United States
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
University of Utah Huntsman Cancer Institute
Salt Lake City, Utah, 84112, United States
-
Universitätsklinikum Heidelberg
Heidelberg, 69120, Germany
-
Universitätsklinikum Schleswig Holstein Campus Kiel
Kiel, 24105, Germany
-
Wake Forest Baptist Health
Winston-Salem, North Carolina, 27157, United States
-
Washington University
St Louis, Missouri, 63110, United States
-
Winship Cancer Institute Emory U
Atlanta, Georgia, 30322, United States
Conditions
Explore the condition pages connected to this study.